ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
Here's why the ResMed share price is sinking 6% today
Healthcare Shares
ResMed share price on watch after Q3 revenue and earnings miss
Share Market News
5 things to watch on the ASX 200 on Friday
Healthcare Shares
Analysts name 2 ASX 200 healthcare shares to buy
Growth Shares
3 fantastic ASX growth shares with major upside potential
Broker Notes
Top brokers name 3 ASX shares to buy next week
Blue Chip Shares
2 blue chip ASX 200 shares analysts rate as buys this month
Broker Notes
Broker names 3 of the best ASX 200 shares to buy in April
Growth Shares
Growth will be back! Expert picks 7 ASX shares to buy now
Growth Shares
Experts name 3 excellent ASX shares for growth investors to buy
Healthcare Shares
3 ASX healthcare shares rated as buys by a leading broker
Share Fallers
Why Aurelia Metals, Janus Henderson, ResMed, and Zip shares are dropping
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
